Advertisement

Formulation and Process Development for Lyophilized Biological Reference Materials

  • Paul MatejtschukEmail author
  • Kiran Malik
  • Chinwe Duru
Protocol
Part of the Methods in Pharmacology and Toxicology book series (MIPT)

Abstract

Biologicals can often be inherently unstable in the liquid state and require lyophilization to ensure long-term stability. We describe our approach to the lyophilization of a wide range of biological reference materials, many prepared as part of our work on behalf of the WHO, to develop freeze-dried reference materials to assign biological activity. These can cover a wide range of materials, often purified proteins and sera but also including nucleic acids and viruses. Recent trends in optimizing our approach are presented; the importance of noninvasive monitoring is illustrated and the challenges of formulation design and cycle optimization are discussed.

Key words

Biological reference materials Formulation Cycle optimization Design of experiments Nucleic acids Viruses 

Notes

Acknowledgments

We thank our many colleagues at NIBSC with whom development studies have been undertaken and those in the Standards Processing Division with whom we cooperate to deliver large-scale batches of lyophilized material. We also thank academic collaborators, especially Professor Paul Dalby, UCL and former students Drs. Mathew Robinson and Yitzchak Grant.

References

  1. 1.
    WHO (2006) Recommendations for the preparation, characterization and establishment of international and other biological reference standards (revised 2004), WHO technical report series, No. 932. WHO, Geneva, pp 75–131Google Scholar
  2. 2.
    Phillips P (1998) The preparation of International Biological Standards. Fresenius J Anal Chem 360:473–475.  https://doi.org/10.1007/s002160050742CrossRefGoogle Scholar
  3. 3.
    Matejtschuk P, Anderson M, Jefferson P (2010) Lyophilization of biological standards. In: Rey L, May JC (eds) Lyophilization/freeze drying of pharmaceutical & biological products, 3rd edn. Informa, New York, NY, pp 317–352Google Scholar
  4. 4.
    Matejtschuk P, Rafiq S, Johnes S, Gaines Das R (2005) A comparison of vials with ampoules for the storage of biological reference materials. Biologicals 33(2):63–70CrossRefGoogle Scholar
  5. 5.
    Kett V (2009) Thermal Analysis - the use of DSC & MTDSC in analyzing freeze-dried formulations and products. Am Pharm Rev 12:24–29Google Scholar
  6. 6.
    Meister E, Gieseler H (2009) Freeze-dry microscopy of protein/sugar mixtures: drying behavior, interpretation of collapse temperatures and a comparison to corresponding glass transition data. J Pharm Sci 98:3072–3087CrossRefGoogle Scholar
  7. 7.
    Meister E, Sasi S, Gieseler H (2009) Freeze-dry microscopy: impact of nucleation temperature and excipient concentration on collapse temperature data. AAPS PharmSciTech 10(2):582–588.  https://doi.org/10.1208/s12249-009-9245-yCrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Adams GDJ (1991) The loss of substrate from a vial during freeze-drying using Escherichia coli as a trace organism. J Chem Technol Biotechnol 52(4):511–518CrossRefGoogle Scholar
  9. 9.
    Cook IA, Ward KR (2011) Applications of headspace moisture analysis for investigating the water dynamics within a sealed vial containing freeze-dried material. PDA J Pharm Sci Technol 65:2–11CrossRefGoogle Scholar
  10. 10.
    Cook IA, Ward KR (2011) Headspace moisture mapping and the information that can be gained about freeze-dried materials and processes. PDA J Pharm Sci Technol 65(5):457–467.  https://doi.org/10.5731/pdajpst.2011.00760CrossRefPubMedGoogle Scholar
  11. 11.
    Jones JA, Last IR, MacDonald BF, Prebble KA (1993) Development and transferability of near-infrared methods for determination of moisture in a freeze-dried injection product. J Pharm Biomed Anal 11:1227–1231CrossRefGoogle Scholar
  12. 12.
    Kamat MS, Lodder RA, DeLuca PP (1989) Near Infra red spectroscopic determination of residual moisture in lyophilized sucrose through intact glass vials. Pharm Res 6(11):961–965CrossRefGoogle Scholar
  13. 13.
    Lin TP, Hsu CC (2002) Determination of residual moisture in lyophilized protein pharmaceuticals using a rapid and noninvasive method: near infrared spectroscopy. PDA J Pharm Sci Technol 56(4):196–205PubMedGoogle Scholar
  14. 14.
    Malik KP, Duru C, Ahmed M, Matejtschuk P (2010) Analytical options for the measurement of residual moisture content in lyophilized biological materials. Am Pharm Rev 13(5):42–47Google Scholar
  15. 15.
    Ferguson M, Wilkinson DE, Heath A, Matejtschuk P (2011) The first international standard for antibodies to HPV 16. Vaccine 29(38):6520–6526CrossRefGoogle Scholar
  16. 16.
    De Beer TR, Vercruysse P, Burggraeve A, Quinten T, Ouyang J, Zhang X, Vervaet C, Remon JP, Baeyens WR (2009) In-line and real-time process monitoring of a freeze drying process using Raman and NIR spectroscopy as complementary process analytical technology (PAT) tools. J Pharm Sci 98(9):3430–3446.  https://doi.org/10.1002/jps.21633CrossRefPubMedGoogle Scholar
  17. 17.
    Kauppinen A, Toiviainen M, Korhonen O, Aaltonen J, Järvinen K, Paaso J, Juuti M, Ketolainen J (2013) In-line multipoint near-infrared spectroscopy for moisture content quantification during freeze-drying. Anal Chem 85(4):2377–2384CrossRefGoogle Scholar
  18. 18.
    De Jonge J, Amorij JP, Hinrichs WL, Wilschut J, Huckriede A, Frijlink HW (2007) Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage. Eur J Pharm Sci 32(1):33–44CrossRefGoogle Scholar
  19. 19.
    Pastorino B, Baronti C, Gould EA, Charrel RN, de Lamballerie X (2015) Effect of chemical stabilizers on the thermostability and infectivity of a representative panel of freeze-dried viruses. PLoS One 10(4):e0118963.  https://doi.org/10.1371/journal.pone.0118963CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Fryer JF, Heath AB, Wilkinson DE, Minor PD (2017) A collaborative study to establish the 3rd WHO International Standard for hepatitis B virus for nucleic acid amplification techniques. Biologicals 46:57–63CrossRefGoogle Scholar
  21. 21.
    Fryer JF, Heath AB, Minor PD, Collaborative Study Group (2016) A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology. Biologicals 44(4):242–251CrossRefGoogle Scholar
  22. 22.
    Fryer JF, Heath AB, Wilkinson DE, Minor PD, Collaborative Study Group (2016) A collaborative study to establish the 1st WHO International Standard for Epstein-Barr virus for nucleic acid amplification techniques. Biologicals 44(5):423–433.  https://doi.org/10.1016/j.biologicals.2016.04.010CrossRefPubMedGoogle Scholar
  23. 23.
    Hansen LJ, Daoussi R, Vervaet C, Remon JP, De Beer TR (2015) Freeze-drying of live virus vaccines: a review. Vaccine 33(42):5507–5519.  https://doi.org/10.1016/j.vaccine.2015.08.085CrossRefPubMedGoogle Scholar
  24. 24.
    Natan D, Nagler A, Arav A (2009) Freeze-drying of mononuclear cells derived from umbilical cord blood followed by colony formation. PLoS One 4(4):e5240.  https://doi.org/10.1371/journal.pone.0005240CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Arav A, Natan D (2012) Freeze drying of red blood cells: the use of directional freezing and a new radio frequency lyophilization device. Biopreserv Biobank 10(4):386–394.  https://doi.org/10.1089/bio.2012.0021CrossRefPubMedGoogle Scholar
  26. 26.
    Ward K, Cowen A, Peacock T (2012) Freeze drying method. WO2012098358 A1Google Scholar
  27. 27.
    Loi P, Iuso D, Czernik M, Zacchini F, Ptak G (2013) Towards storage of cells and gametes in dry form. Trends Biotechnol 31(12):688–695.  https://doi.org/10.1016/j.tibtech.2013.09.004CrossRefPubMedGoogle Scholar
  28. 28.
    White HE, Matejtschuk P, Rigsby P, Gabert J, Lin F, Wang YL, Branford S, Müller MC, Beaufils N, Beillard E, Colomer D, Dvorakova D, Ehrencrona H, Goh HG, El Housni H, Jones D, Kairisto V, Kamel-Reid S, Kim DW, Langabeer S, Ma ES, Press RD, Romeo G, Wang L, Zoi K, Hughes T, Saglio G, Hochhaus A, Goldman JM, Metcalfe P, Cross NC (2010) Establishment of the 1st World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood 116(22):e111–e117.  https://doi.org/10.1182/blood-2010-06-291641 PMID: 20720184CrossRefPubMedGoogle Scholar
  29. 29.
    Gray E, Hawkins JR, Morrison M, Hawkins M, Byrne E, Kitchen S, Jennings I, Makris M, Preston FE, Metcalfe P (2006) Establishment of the 1st International Genetic Reference Panel for factor V Leiden (G1691A), human gDNA. Thromb Haemost 96:215–219CrossRefGoogle Scholar
  30. 30.
    Cranage MP, Gurner BW, Coombs RR (1983) Glutaraldehyde stabilisation of antibody-linked erythrocytes for use in reverse passive and related haemagglutination assays. J Immunol Methods 64(1-2):7–16CrossRefGoogle Scholar
  31. 31.
    Matejtschuk P, Easter G, Thorpe R, Coombs RR (1988) Experimental studies on red cell-based assays for total IgE and allergen-specific IgE. Int Arch Appl Immunol 86(1):106–111CrossRefGoogle Scholar
  32. 32.
    Stebbings R, Wang L, Sutherland J, Kammel M, Gaigalas AK, John M, Roemer B, Kuhne M, Schneider RJ, Braun M, Engel A, Dikshit DK, Abbasi F, Marti GE, Sassi MP, Revel L, Kim SK, Baradez MO, Lekishvili T, Marshall D, Whitby L, Jing W, Ost V, Vonsky M, Neukammer J (2015) Quantification of cells with specific phenotypes I: determination of CD4+ cell count per microliter in reconstituted lyophilized human PBMC prelabeled with anti-CD4 FITC antibody. Cytometry A 87(3):244–253.  https://doi.org/10.1002/cyto.a.22614CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Wang W (2000) Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 203:1–60CrossRefGoogle Scholar
  34. 34.
    Costantino HR (2004) Excipients for use in lyophilized pharmaceutical peptide, protein and other bioproducts. In: Costantino HR, Pikal MJ (eds) Lyophilization of biopharmaceuticals. AAPS Press, Arlington, VA, pp 139–228Google Scholar
  35. 35.
    Johnson RE, Kirchhoff CF (2002) Gaud HT (2002) Mannitol–sucrose mixtures—versatile formulations for protein lyophilization. J Pharm Sci 91:914–922CrossRefGoogle Scholar
  36. 36.
    Duru C, Swann C, Dunleavy U, Mulloy B, Matejtschuk P (2015) The importance of formulation in the successful lyophilization of influenza reference materials. Biologicals 43(2):110–116.  https://doi.org/10.1016/j.biologicals.2014.12.001CrossRefPubMedGoogle Scholar
  37. 37.
    Mawas F, Bolgiano B, Rigsby P, Crane D, Belgrave D, Corbel MJ (2007) Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide. Biologicals 35(4):235–245CrossRefGoogle Scholar
  38. 38.
    Stickings P, Rigsby P, Coombes L, Malik K, Matejtschuk P, Sesardic D (2010) Collaborative study for the calibration of a replacement international standard for diphtheria toxoid adsorbed. Biologicals 38(5):529–538CrossRefGoogle Scholar
  39. 39.
    Grant Y, Matejtschuk P, Dalby PA (2009) Rapid optimization of protein freeze-drying formulations using ultra scale-down and factorial design of experiment in microplates. Biotechnol Bioeng 104:957–964CrossRefGoogle Scholar
  40. 40.
    Grant Y, Matejtschuk P, Bird C, Wadhwa M, Dalby PA (2012) Freeze drying formulation using microscale and of experiment approaches: a case study using granulocyte colony-stimulating factor. Biotechnol Lett 34(4):641–648.  https://doi.org/10.1007/s10529-011-0822-2CrossRefPubMedGoogle Scholar
  41. 41.
    Smith G, Arshad MS, Polygalov E, Ermolina I, McCoy TR, Matejtschuk P (2017) Process understanding in freeze-drying cycle development: applications for through-vial impedance spectroscopy (TVIS) in mini-pilot studies. J Pharm Innov 12:26.  https://doi.org/10.1007/s12247-016-9266-5CrossRefGoogle Scholar
  42. 42.
    Matejtschuk P, Phillips PK (2008) Product stability and accelerated degradation studies. In: Stacey G, Davis JM (eds) Medicines from animal cell culture. Wiley, Chichester, UK pp 503–522Google Scholar
  43. 43.
    Robinson MJ, Matejtschuk P, Bristow AF, Dalby PA (2018) Tm-values and unfolded fraction can predict aggregation rates for granulocyte colony stimulating factor variant formulations but not under predominantly native conditions. Mol Pharm 15:256.  https://doi.org/10.1021/acs.molpharmaceut.7b00876CrossRefPubMedGoogle Scholar
  44. 44.
    Malik K, Matejtschuk P, Thelwell C, Burns C (2013) Differential scanning fluorimetry: rapid screening of formulations that promote the stability of reference preparations. J Pharm Biomed Anal 77:163–166CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.National Institute for Biological Standards & Control (NIBSC)Potters BarUK
  2. 2.Standardisation ScienceNational Institute for Biological Standards & Control (NIBSC)Potters BarUK

Personalised recommendations